Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory
Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Ince
![PDF) Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much? | Anna Krajcovicova and Tibor Hlavaty - Academia.edu PDF) Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much? | Anna Krajcovicova and Tibor Hlavaty - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/49658462/mini_magick20220701-11455-1duqnke.png?1656702366)
PDF) Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much? | Anna Krajcovicova and Tibor Hlavaty - Academia.edu
Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfα-Blocking Agents In Inflammatory Bowel Disease Patients I
![Patrick van Rheenen on Twitter: "Crohn's Disease treatment decision tree (after ECCO/ESPGHAN guideline) https://t.co/9KoHlv9n5g #ESPGHAN2014 http://t.co/NByj5HD7E2" / Twitter Patrick van Rheenen on Twitter: "Crohn's Disease treatment decision tree (after ECCO/ESPGHAN guideline) https://t.co/9KoHlv9n5g #ESPGHAN2014 http://t.co/NByj5HD7E2" / Twitter](https://pbs.twimg.com/media/Bp7zMunCQAE-diZ.jpg:large)
Patrick van Rheenen on Twitter: "Crohn's Disease treatment decision tree (after ECCO/ESPGHAN guideline) https://t.co/9KoHlv9n5g #ESPGHAN2014 http://t.co/NByj5HD7E2" / Twitter
![Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1873994614001482-gr2.jpg)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect
![PDF) Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study | Daniela Lazar - Academia.edu PDF) Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study | Daniela Lazar - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/48803271/mini_magick20190202-12417-owu6dm.png?1549134452)
PDF) Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study | Daniela Lazar - Academia.edu
![PDF) Exposure-Efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease PDF) Exposure-Efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease](https://i1.rgstatic.net/publication/315612371_Exposure-Efficacy_Relationships_for_Vedolizumab_Induction_Therapy_in_Patients_with_Ulcerative_Colitis_or_Crohn's_Disease/links/5d588113a6fdccb7dc457382/largepreview.png)
PDF) Exposure-Efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
![Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: medical treatment | Frontline Gastroenterology Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: medical treatment | Frontline Gastroenterology](https://fg.bmj.com/sites/default/files/highwire/flgastro/13/2.cover-source.jpg)
Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: medical treatment | Frontline Gastroenterology
![Dr Paul Wiesel, gastro-entérologue à Lausanne - Crohn - Mise à jour 2014 des recommandations ECCO sur la maladie de Crohn. Quoi de neuf? Dr Paul Wiesel, gastro-entérologue à Lausanne - Crohn - Mise à jour 2014 des recommandations ECCO sur la maladie de Crohn. Quoi de neuf?](https://www.drpaulwiesel.ch/cms/images/crohn3.jpg)
Dr Paul Wiesel, gastro-entérologue à Lausanne - Crohn - Mise à jour 2014 des recommandations ECCO sur la maladie de Crohn. Quoi de neuf?
![PDF) Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease PDF) Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease](https://i1.rgstatic.net/publication/269766071_Prognosis_of_Primary_Sclerosing_Cholangitis_in_Israel_is_Independent_of_Coexisting_Inflammatory_Bowel_Disease/links/6202255f80f0ea5eb5361c24/largepreview.png)
PDF) Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease
![PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/322890443_DOP028_Second_N-ECCO_Consensus_Statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5c7fc64592851c69505a7e20/largepreview.png)
PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
![Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1873994614001482-gr1.jpg)